Blennow K - Search Results

1

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.

Blom ES, Giedraitis V, Zetterberg H, Fukumoto H, Blennow K, Hyman BT, Irizarry MC, Wahlund LO, Lannfelt L, Ingelsson M. Blom ES, et al. Among authors: blennow k. Dement Geriatr Cogn Disord. 2009;27(5):458-64. doi: 10.1159/000216841. Epub 2009 May 7. Dement Geriatr Cogn Disord. 2009. PMID: 19420940 Free PMC article.

2

Quantitative changes in the amyloid beta A4 precursor protein in Alzheimer cerebrospinal fluid.

Prior R, Mönning U, Schreiter-Gasser U, Weidemann A, Blennow K, Gottfries CG, Masters CL, Beyreuther K. Prior R, et al. Among authors: blennow k. Neurosci Lett. 1991 Mar 11;124(1):69-73. doi: 10.1016/0304-3940(91)90824-d. Neurosci Lett. 1991. PMID: 1677459

3

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

Blennow K, Hesse C, Fredman P. Blennow K, et al. Neuroreport. 1994 Dec 20;5(18):2534-6. doi: 10.1097/00001756-199412000-00032. Neuroreport. 1994. PMID: 7696597

4

Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease?

Blennow K, Davidsson P, Wallin A, Ekman R. Blennow K, et al. Dementia. 1995 Nov-Dec;6(6):306-11. doi: 10.1159/000106963. Dementia. 1995. PMID: 8563783 Clinical Trial.

5

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Blennow K, et al. Mol Chem Neuropathol. 1995 Dec;26(3):231-45. doi: 10.1007/BF02815140. Mol Chem Neuropathol. 1995. PMID: 8748926

6

Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.

Landén M, Hesse C, Fredman P, Regland B, Wallin A, Blennow K. Landén M, et al. Among authors: blennow k. Dementia. 1996 Sep-Oct;7(5):273-8. doi: 10.1159/000106892. Dementia. 1996. PMID: 8872419

7

The neurochemistry of Alzheimer's disease.

Blennow K, Cowburn RF. Blennow K, et al. Acta Neurol Scand Suppl. 1996;168:77-86. doi: 10.1111/j.1600-0404.1996.tb00378.x. Acta Neurol Scand Suppl. 1996. PMID: 8997425 Review.

8

Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients.

Augustinsson LE, Blennow K, Blomstrand C, Bråne G, Ekman R, Fredman P, Karlsson I, Kihlgren M, Lehmann W, Lekman A, Månsson JE, Ramström I, Wallin A, Wikkelsö C, Gottfries CG, Svennerholm L. Augustinsson LE, et al. Among authors: blennow k. Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):26-33. doi: 10.1159/000106597. Dement Geriatr Cogn Disord. 1997. PMID: 8997549 Clinical Trial.

9

Gangliosides and sulfatide in cerebrospinal fluid in leukoaraiosis.

Tarvonen-Schröder S, Blennow K, Lekman A, Fredman P, Räihä I, Sourander L. Tarvonen-Schröder S, et al. Among authors: blennow k. Dement Geriatr Cogn Disord. 1997 May-Jun;8(3):174-9. doi: 10.1159/000106628. Dement Geriatr Cogn Disord. 1997. PMID: 9137896

10

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Andreasen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, Räihä I, Sourander L, Winblad B, Blennow K. Andreasen N, et al. Among authors: blennow k. J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):298-305. doi: 10.1136/jnnp.64.3.298. J Neurol Neurosurg Psychiatry. 1998. PMID: 9527138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,199 results

Search Page

Filters